Breaks Categories: News

FridayMar 17, 2017 12:28 pm

NetworkNewsBreaks – BioSig Technologies, Inc. (BSGM) Signs Strategic Agreement with Mayo Clinic

BioSig Technologies (OTCQB: BSGM) shares rose 10% after the company signed a 10-year strategic agreement with Mayo Clinic and Mayo Clinic Ventures. The new agreement expands upon the work realized under the Advanced Clinical Research Program that was signed with Mayo Clinic in March 2016. The company intends to work closely with leading Mayo electrophysiologists Drs. Samuel Asirvatham and K. L. Venkatachalam to develop advanced clinical features and applications for its PURE EP System, in addition to leveraging its experience in physiologic signal processing to develop future technologies. Mayo is expected to contribute knowledge, intellectual property and clinical support to the partnership. The…

Continue Reading

FridayMar 17, 2017 10:52 am

NetworkNewsBreaks – Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) Enters Agreement to Merge with Molecular Templates; Shares Soar

Threshold Pharmaceuticals (NASDAQ: THLD) shares soared 41% following early morning news that the company has entered into a definitive agreement to merge with Molecular Templates, Inc., a privately held biopharmaceutical company. Per the agreement, Molecular Templates will merge with a wholly-owned subsidiary of Threshold in an all-stock transaction, resulting in a combined Nasdaq-listed company focused on the development of novel treatments for cancer. At the close of the transaction, Longitude Capital will invest $20 million, subject to certain conditions, including the receipt of additional equity financing commitments of $20 million. Molecular Templates’ proprietary technology has been used to create biologic…

Continue Reading

ThursdayMar 16, 2017 12:35 pm

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) CEO Featured in Benzinga Article

India Globalization Capital (NYSE: IGC) was recently featured in an article detailing the company's strategic move to the cannabis industry and future plans for the company. In the past, IGC was a company primarily focused on the beneficiation of iron ore. That focus changed a few years ago when iron ore prices plummeted, often selling below its cost of production. For the last three years, the company has shifted its focus to tackling the cannabis industry, or more specifically, medical cannabis use. The company is currently developing a portfolio to address epilepsy, cachexia, PTSD, Alzheimer’s, and Parkinson’s. “We came up…

Continue Reading

ThursdayMar 16, 2017 12:24 pm

NetworkNewsBreaks – Avid’s (NASDAQ: AVID) Avid NEXIS™ Selected by Middlesex University; Shares Sink

Avid® (NASDAQ: AVID) shares are down 18% in mid-day trade. The company this morning said that the Faculty of Arts and Creative Industries at Middlesex University in London has invested in Avid NEXIS™. Powered by the MediaCentral® Platform, Avid NEXIS provides the reliability, performance and scalability that the faculty needs to support the expanding department and prepare graduates for success in the media industries. The university faculty and stake holders have invested in Avid NEXIS | E4 and Avid NEXIS | E2 systems with the addition of a System Director Appliance for the flexibility to support the increasing needs of…

Continue Reading

ThursdayMar 16, 2017 10:40 am

NetworkNewsBreaks – Player’s Network, Inc. (PNTV) Announces Engagement of NetworkNewsWire

Diversified holding company Player's Network, Inc. (OTCQB: PNTV) this morning announced its engagement of NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging an investor-based distribution network that includes more than 5,000 key syndication outlets, various newsletters, numerous social media channels, blogs, and other outreach tools, NNW will look to generate greater brand awareness for Player’s Network as the company seeks to expand its presence in both the media and cannabis industries. “This partnership is an extension of our new shareholder…

Continue Reading

ThursdayMar 16, 2017 9:54 am

NetworkNewsBreaks – eXp World Holdings, Inc. (EXPI) Reaches 3,000 Agents through eXp Realty LLC

eXp World Holdings, Inc. (OTCQB: EXPI), holding company for the Agent-Owned Cloud Brokerage®, this morning announced that eXp Realty’s family of agents and brokers now includes more than 3,000 members across its operating markets in the United States and Canada. This figure represents a 25 percent increase from the company’s total of 2,401 agents at the end of 2016, as well as an increase of more than 200 percent year-over-year. “eXp Realty continues to attract an increasing number of top agents, teams and brokers, which has catapulted us to a place alongside the top residential brokerage firms in the country,”…

Continue Reading

ThursdayMar 16, 2017 9:30 am

NetworkNewsBreaks – Social Reality, Inc. (NASDAQ: SRAX) to Host 2016 Financial Results Conference Call on March 30

Internet advertising company Social Reality, Inc. (NASDAQ: SRAX) this morning announced plans to host a conference call discussing its fourth quarter 2016 financial results at 1:30 pm PT on March 30, 2017. In addition to giving prospective investors a financial and operational summary of SRAX’s progress during 2016, CEO Christopher Miglino and CFO J.P. Hannan are expected to offer insight into the company’s vision for the coming months during the call. To access the conference call, investors should dial (877) 681-3372 if calling from the United States or Canada, or (719) 325-4907 if calling internationally. The passcode for both numbers…

Continue Reading

TuesdayMar 14, 2017 11:12 am

NetworkNewsBreaks – TapImmune, Inc. (NASDAQ: TPIV) HER2-Targeted Vaccine to be Evaluated in Phase 2 Study Funded by US Department of Defense

Clinical-stage immuno-oncology company TapImmune, Inc. (NASDAQ: TPIV) this morning announced that its collaborators at the Mayo Clinic recently received a $3.7 million grant from the U.S. Department of Defense (DoD) to conduct a Phase 2 clinical study on the company’s HER2/neu-targeted T-cell vaccine. The DoD-funded study will evaluate women diagnosed with an early form of breast cancer called ductal carcinoma in situ (DCIS), and, if successful, could clear the way for TapImmune’s vaccine to replace standard surgery and chemotherapy by becoming part of a routine immunization schedule for preventing breast cancer in healthy women. “This is our second T-cell vaccine…

Continue Reading

TuesdayMar 14, 2017 10:12 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Expands Presence in Cannabis Industry through Acquisition of Stake in Convectium

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced that it has closed its first round of funding to acquire a stake in Jacksam Corp., dba Convectium, the developer of a unique oil filling system poised to revolutionize the cannabis industry. Originally announced at the end of January, the Convectium acquisition is expected to include an overall investment of stock and cash consideration totaling $800,000, which Convectium will use to help fund its growth as well as marketing of its revolutionary 710Shark and 710Seal system. Leaning on the marketability of the first-of-its-kind system, as well as its line of…

Continue Reading

TuesdayMar 14, 2017 9:22 am

NetworkNewsBreaks – GreeneStone Healthcare Corp. (GRST) Announces Engagement of NetworkNewsWire

Healthcare services company GreeneStone Healthcare Corp. (OTCQB: GRST) this morning announced its engagement of NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging an investor-based distribution network that includes more than 5,000 key syndication outlets, various newsletters, numerous social media channels, blogs, and other outreach tools, NNW will look to generate greater brand awareness for GreeneStone as it works to expand its presence in the U.S. treatment market through its newly-acquired facility in Delray Beach, Florida. “We are pleased to partner…

Continue Reading